Ranjani Raghavan

Healthcare

Intas Pharmaceuticals Ltd is preparing a bid for Biogen Inc.’s biosimilar business in a transaction that could be valued at ......

ChrysCapital-backed Intas Pharma weighs $1-bn bid for Biogen's biosimilars biz

VC_Desk_Section_Masthead

VC_Desk_Section_A_300x250

VC_Desk_Section_B_300x250

VC_Desk_Section_C_300x250

VC_Desk_Section_D_300x250

VC_Desk_Section_E_300x250

VC_Desk_Section_A_Skyscraper

VC_Desk_Section_B_Skyscraper

VC_Desk_Section_A_Billboard

VC_Desk_Section_B_Billboard

VC_Desk_Section_C_Billboard

VC_Desk_Section_D_Billboard

VC_Desk_Section_E_Billboard

VC_Desk_Section_Footer

VCCircle_WAP_Section_Masthead

VCCircle_WAP_Section_Sticky

VCCircle_WAP_Section_A_300x250

VCCircle_WAP_Section_B_300x250

VCCircle_WAP_Section_C_300x250

VCCircle_WAP_Section_D_300x250

VCCircle_WAP_Section_Bottom_300x250

Latest Goldman Sachs Group Inc news, Goldman Sachs Group Inc News,  Goldman Sachs Group Inc Funding, Goldman Sachs Group Inc Fund and articles about Goldman Sachs Group Inc on Vccircle.

Latest Goldman Sachs Group Inc News | Goldman Sachs Group Inc News | Goldman Sachs Group Inc Funding | Goldman Sachs Group Inc Fund - vccircle

Goldman Sachs Group Inc

Goldman Sachs Group Inc

Healthcare

ChrysCapital-backed Intas Pharma weighs $1-bn bid for Biogen's biosimilars biz

Most Popular

Google News